American Society of Hematology

banner image

ASH Meeting on Hematologic Malignancies

Advance registration is now open. Hear top experts in hematologic malignancies discuss the latest development in clinical care.

Learn more
banner image

CAPS Draft Recommendations

Draft recommendations from "Diagnosis and Management of Catastrophic Antiphospholipid Syndrome: a Clinical Practice Guideline" are now available for review and comment.

Learn more
banner image

Call for Abstracts

Submit your research for an opportunity to present at the 59th ASH Annual Meeting.

Learn more

Support Medical Research

Urge your members of Congress to support continued medical research funding.

Take action
Find a Hematologist

Find a Hematologist

Search a database of practicing hematologists in your area.

Learn more
Support Hematology

ASH Foundation

Help move hematology forward by supporting research, career development, and quality care and education programs.

Learn more
Join ASH

ASH Membership

Become part of a global network of more than 16,000 hematologists working to conquer blood diseases.

Learn more
View all press releases
  • ACA Update

    The House of Representatives released legislation, titled the “American Health Care Act,” to repeal the Affordable Care Act.  As written, ASH has serious concerns that this legislation will reduce overall access to coverage and treatment and would greatly impact patients with hematologic diseases and disorders.

  • DEA Eliminates Grace Period for Registration Renewal

    Through a notice on its website, the Drug Enforcement Administration (DEA) recently announced significant changes to its registration renewal process. Effective January 1, 2017, the DEA is eliminating the informal grace period which the agency has previously allowed for registrants to renew their registrations. 

  • CMS Announces End to Medicare Part B Drug Payment Model

    On December 15, 2016, the Centers for Medicare and Medicaid Services (CMS) announced the cancellation of Medicare Part B Drug Payment Model.  CMS initially proposed the demonstration on March 8, 2016 to test new models in how physician-administered drugs are paid under the Medicare program.

  • NHLBI Small Business Innovation Research Funding Opportunity Fosters Production of Blood Cells From Stem Cells

    ASH is pleased to see the National Heart, Lung and Blood Institute’s (NHLBI) continuous support (RFA-HL-15-030) for the development of improved techniques to enhance the production of clinically relevant, functional stem cell-derived red blood cells or platelets.

View all policy news
  • The Case for Abandoning Induction Chemotherapy

    Dr. Pollyea discusses reconsidering the treatment of acute myeloid leukemia solely with intensive induction chemotherapy.

  • Planting Evidence

    Review the peripheral blood smear to determine the diagnosis of a 31-year-old man referred to hematology clinic for evaluation of long-standing thrombocytopenia.

  • When More (Oxygen) Is Not Better

    Take the challenge to learn what test is most likely to yield the diagnosis for a case of a 58-year-old Asian woman with history of inclusion body myositis on high-dose corticosteroids and methotrexate, noted to be hypoxic.

  • Blasts of a Different Sort

    Can you tell what the diagnosis is for a man with a history of recurrent necrotizing pancreatitis and end-stage renal disease on intermittent hemodialysis by looking at his bone marrow biopsy?

View all Hematologist articles